Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells
- PMID: 8833657
- DOI: 10.1210/mend.10.3.8833657
Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells
Abstract
We have investigated the autocrine regulation of insulin-like growth factor-II (IGF-II) signaling by the insulin-like growth factor-I receptor (IGF-IR) and the insulin-like growth factor-II/mannose 6-phosphate receptor (IGF-IIR) in MCF-7 breast cancer cells, employing retroviruses encoding both IGF-I, IGF-II, and IGF-I and II mutants with reductions in affinity for either the IGF-IR or the IGF-IIR. These studies revealed reciprocal roles for IGF-IR and IGF-IIR affinity in the regulation of autocrine IGF-II activity. IGF-IR affinity was required for serum-free proliferation but also for efficient IGF-II secretion. In contrast, cellular proliferation, receptor tyrosine kinase-dependent signaling, and extracellular IGF-II protein accumulation were all reduced in the presence of IGF-IIR affinity. Inhibition of IGF-II signaling appeared to be the sole consequence of IGF-IIR affinity, as no cellular responses attributable to selective IGF-IIR binding by a reduced IGF-IR affinity IGF-II mutant could be detected. By operating as an IGF-II antagonist, the IGF-IIR has tumor suppressor-like properties, a suggestion consistent with reports of loss of heterozygosity at the IGF-IIR locus in a variety of human malignancies.
Similar articles
-
Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):185-96. doi: 10.1016/j.jsbmb.2007.10.006. Epub 2008 Feb 8. J Steroid Biochem Mol Biol. 2008. PMID: 18337089
-
Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.Endocrinology. 1997 Oct;138(10):4390-400. doi: 10.1210/endo.138.10.5265. Endocrinology. 1997. PMID: 9322955
-
Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo.Int J Cancer. 2003 Nov 20;107(4):564-70. doi: 10.1002/ijc.11453. Int J Cancer. 2003. PMID: 14520693
-
Molecular mechanisms underlying insulin-like growth factor action: How mutations in the GH: IGF axis lead to short stature.Pediatr Endocrinol Rev. 2011 Jun;8(4):374-81. Pediatr Endocrinol Rev. 2011. PMID: 21972777 Review.
-
Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development.Biosci Rep. 2006 Feb;26(1):7-17. doi: 10.1007/s10540-006-9002-3. Biosci Rep. 2006. PMID: 16779663 Review.
Cited by
-
The role of the insulin-like growth factor-1 system in breast cancer.Mol Cancer. 2015 Feb 15;14:43. doi: 10.1186/s12943-015-0291-7. Mol Cancer. 2015. PMID: 25743390 Free PMC article. Review.
-
Effect of Expansion Media on Functional Characteristics of Bone Marrow-Derived Mesenchymal Stromal Cells.Cells. 2023 Aug 19;12(16):2105. doi: 10.3390/cells12162105. Cells. 2023. PMID: 37626914 Free PMC article.
-
Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells.BMC Cancer. 2002 Jul 30;2:18. doi: 10.1186/1471-2407-2-18. BMC Cancer. 2002. PMID: 12149131 Free PMC article.
-
Synergistic effects of hormones on structural and functional maturation of cardiomyocytes and implications for heart regeneration.Cell Mol Life Sci. 2023 Aug 5;80(8):240. doi: 10.1007/s00018-023-04894-6. Cell Mol Life Sci. 2023. PMID: 37541969 Free PMC article. Review.
-
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.J Cell Physiol. 2000 Apr;183(1):1-9. doi: 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J. J Cell Physiol. 2000. PMID: 10699960 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
